Helaina: Helaina Raises $20M in Series A Funding

Helaina, a NYC-based company using precision fermentation to recreate immune-equivalent proteins previously only available in breast milk, raised $20m in Series A funding. The round, which brought total capital raised to $24.6m, was co-led by Spark Capital and Siam Capital, with participation from Primary Venture Partners, Plum Alley Investments, Tom Williams, Hannah Bronfman, Gabrielle Union, Matt Rutler and Barrel Ventures, among other strategic [...]The post Helaina Raises $20M in Series A Funding appeared first on FinSMEs.